Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02214836 · ClinicalTrials.gov registry record · NA

Ultrasound Imaging of Kidney Stones and Lithotripsy

A NA study of Nephrolithiasis and Kidney Stones, sponsored by University of Washington.

Active
Registry status
NA
Development phase
370
Enrollment target
1
Study location

NCT02214836: Active NA study of Nephrolithiasis and Kidney Stones, sponsored by University of Washington.

NCT02214836 is a NA study of Nephrolithiasis and Kidney Stones that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 370 participants, above the 101-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (266% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02214836, a NA study of Nephrolithiasis and Kidney Stones, is active but no longer recruiting, sponsored by University of Washington.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
370 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether new software processing of ultrasound images can improve detection and size determination of kidney stones.

Primary Outcome

Number and location of stones will be measured in one research procedure at the time of the procedure. These will be compared to measurements of number and location made in the clinical surgery procedure and to measurements from clinical imaging.

Interventions

  • DEVICE Verasonics Data Acquisition System (VDAS)

Study Locations (1)

Washington

  • University of Washington, Department of Urology - Seattle

Trial Details

FieldValue
Enrollment Target 370 participants
Start Date 2015-01-01
Est. Completion 2027-12-31
Phase NA
University of Washington

1,048 total trials

What the registry record for NCT02214836 still lists

NCT02214836 is an interventional study that assigns participants to a tested intervention. The registered 370 participants enrollment target is mid-sized for trials with a published cap, above the 101-participant average among 16 other Nephrolithiasis trials with a reported enrollment target (266% higher).

The record links to 4 conditions, with Nephrolithiasis appearing as the primary indexed condition, and to 1 intervention - of which Verasonics Data Acquisition System (VDAS) is the first listed.

NCT02214836 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT02214836 about?

NCT02214836 is a clinical study titled "Ultrasound Imaging of Kidney Stones and Lithotripsy". The purpose of this study is to determine whether new software processing of ultrasound images can improve detection and size determination of kidney stones.

What is the current status of trial NCT02214836?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 370 participants. The study started on 2015-01-01. Estimated completion is 2027-12-31.

What conditions does trial NCT02214836 study?

This clinical trial studies the following conditions: Nephrolithiasis, Kidney Stones, Urolithiasis, Ureter Stones.

What interventions are being tested in trial NCT02214836?

The interventions under investigation include: Verasonics Data Acquisition System (VDAS) (DEVICE).

Who is sponsoring clinical trial NCT02214836?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02214836 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nephrolithiasis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02214836's enrollment target sits among peer trials

370 2nd of 16 the highest of 16 other Nephrolithiasis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Nephrolithiasis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02332668 · 370 participants · Phase 1

    A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

  • NCT04284436 · 370 participants · NA

    Study in Parkinson Disease of Exercise

  • NCT05026749 · 370 participants · Phase 3

    Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children

  • NCT05125016 · 370 participants · Phase 1

    A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02214836, the US trial registry maintained by the National Library of Medicine. NCT02214836 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.